ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0100

COVID Vaccinations in Patients with Rheumatologic Diseases- perspectives and Disparities in a Safety-net Tertiary Care Hospital in Memphis, Tennessee

Beenish Zulfiqar1, Mohamad Bittar2, Daniel Austin2 and Ashton Hunter2, 1University of Tennessee Health Science Centre, Memphis, TN, 2University of Tennessee Health Science Centre, Memphis, Memphis, TN

Meeting: ACR Convergence 2022

Keywords: COVID-19, Disparities, education, patient, Qualitative Research, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Patients with rheumatologic diseases have had hesitation with COVID-19 vaccines despite the recent reports that they are safe and effective. This might impact underserved populations disproportionately. The aims of this study are: 1- to identify the vaccination rates against Covid-19 and the frequency of vaccine-related adverse events in Rheumatology patients; and 2- to explore the factors associated with lack of vaccination

Methods: This was a questionnaire-based study. Descriptive data on the frequency of vaccine-related adverse events were recorded. Using logistic regression analysis, we studied the association of different factors with patients’ vaccination status. Odds ratios and 95% confidence intervals were reported.

Results: 258 patients participated in the study from October 2021 to January 2022. The most common diagnosis was Rheumatoid arthritis (33%) followed by Systemic Lupus Erythematosus (22%) and osteoarthritis (20.9%). Patients were mostly females (81.8%) and African Americans (72.4%). The majority of patients (61.2%) had elementary school education. 41.4% of patients had Medicare/Medicaid, and 23.4% were uninsured. Three-quarters (73.6%) of patients were vaccinated against Covid-19 with most receiving mRNA vaccines (97%). A quarter of the vaccinated patients stated that they experienced symptoms after the vaccine, mainly myalgias (60%), fatigue (69%), and arm soreness (76.3%). Seven patients reported skin rash. 2 out of 7 had a generalized rash requiring dermatology evaluation and topical steroids while the rest had injection site rash. Twelve patients reported joint swelling, out of them, 3 had not achieved low disease activity prior to being vaccinated requiring escalation of treatment while others did not seek medical care as the swelling was short-lived. For most patients (70%), the symptoms resolved within 24-72 hours. For patients who chose not to get vaccinated, the most common reason was a concern for side effects (88%) and disease flare (82.3%). 35.6% of the patients had a discussion with their providers regarding vaccine hesitation. It was interesting to note that 49.4% of patients who did not receive the vaccine were willing to change their minds if more convincing data emerges. By the time this data was collected, 10.7% of the patients had received their third dose of the vaccine. No statistically significant differences in vaccination status were found based on specific rheumatologic diseases. No difference was found based on race or ethnic background. However, participants with a college degree (adjusted OR= 4.26, p-value 0.0137) and bachelor’s/master’s degrees (adjusted OR=6.48, p-value 0.0173) showed significantly higher rates of vaccination compared to patients with primary education. Low-income participants (Medicaid) had significantly lower rates of vaccination (adjusted OR=0.44, p-value 0.0371)

Conclusion: Based on the findings, we can conclude that the frequency of immune-related adverse events due to COVID vaccines was low and symptoms were mild and short-lived. We can also conclude that lower socio-economic statuses as reflected by education and insurance levels can negatively impact vaccination rates in patients with rheumatologic diseases.

Supporting image 1

Graph 1: Vaccination status by Education level

Supporting image 2

Graph 2: Vaccination status by insurance type

Supporting image 3

Table 1: Side effects after 1st and 2nd dose of vaccines


Disclosures: B. Zulfiqar, None; M. Bittar, None; D. Austin, None; A. Hunter, None.

To cite this abstract in AMA style:

Zulfiqar B, Bittar M, Austin D, Hunter A. COVID Vaccinations in Patients with Rheumatologic Diseases- perspectives and Disparities in a Safety-net Tertiary Care Hospital in Memphis, Tennessee [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/covid-vaccinations-in-patients-with-rheumatologic-diseases-perspectives-and-disparities-in-a-safety-net-tertiary-care-hospital-in-memphis-tennessee/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/covid-vaccinations-in-patients-with-rheumatologic-diseases-perspectives-and-disparities-in-a-safety-net-tertiary-care-hospital-in-memphis-tennessee/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology